These findings indicate that DcR3 may regulate MMP-2 expression via activation of the PI3K/Akt pathway and that this regulation may be one of the important roles of DcR3 as an effector molecule facilitating the progression or metastasis of MFH. This evidence concerns the gene TNFRSF6B and undifferentiated pleomorphic sarcoma.